Benzinga's Top #PreMarket Gainers

Prosensa Holding NV RNA shares jumped 62.15% to $18.55 in pre-market trading after BioMarin Pharmaceutical BMRN announced its plans to acquire Prosensa for $17.75 per share. Cimatron CIMT shares surged 43.56% to $8.70 in pre-market trading after 3D Systems DDD announced its plans to acquire Cimatron for $8.97 per share. Tetraphase Pharmaceuticals TTPH shares rose 16.57% to $25.75 in pre-market trading. According to Bloomberg, Tetraphase Pharma is exploring a sale option after being approached by potential buyers, people familiar with the matter said. Sarepta Therapeutics SRPT shares gained 8.39% to $17.05 in the pre-market trading session after BioMarin Pharmaceutical announced its plans to acquire Prosensa for $17.75 per share.